Clinton Otwori: Which Blood Product Do Healthcare Workers Most Commonly Misunderstand in Practice?
Clinton Otwori, Perioperative Nurse at LifeCare Hospitals, shared a post on LinkedIn:
“Different blood products.
Different purposes.
Different risks.
Not every blood bag hanging in the ward or ICU serves the same purpose.
And understanding the difference can save lives.
Whole Blood still used in many emergency settings for:
- Massive blood loss
- Trauma
- Hemorrhagic shock
Provides:
- Red cells
- Plasma
- Clotting factors
- Platelets
Packed Red Blood Cells (PRBCs)
Used mainly to improve oxygen-carrying capacity in:
- Severe anemia
- Surgical blood loss
- Hemorrhage
Fresh Frozen Plasma (FFP)
Used for:
- Clotting factor replacement
- Coagulopathy
- Liver disease-related bleeding
- Massive transfusion protocols
Platelets
Used when platelet counts are dangerously low or bleeding risk is high.
Common indications include:
- Thrombocytopenia
- Active bleeding
- Platelet dysfunction
Cryoprecipitate
Rich in fibrinogen and clotting factors.
Used in:
- Low fibrinogen states
- Massive bleeding
- Selected DIC cases
The dangerous part?
Two blood products may look similar
But giving the wrong one can:
- Delay treatment
- Worsen complications
- Increase patient risk
And transfusion itself is never risk-free.
Healthcare workers should always watch for:
- Fever/chills
- Shortness of breath
- Rash/itching
- Back or flank pain
- Hypotension or tachycardia
Before any transfusion:
- Verify the patient carefully
- Confirm compatibility
- Monitor closely
- Reassess continuously
Because in critical care…
The right blood product at the right time can save a life.
Which blood product do you think healthcare workers most commonly misunderstand in practice?”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment
-
Oct 19, 2026, 16:04Hussnain Javaid: New EHA Guidelines for HbSC Disease Management
-
Oct 19, 2026, 15:50Deep Madkaiker: A New Academic Opportunity in Transfusion Medicine at ACTREC
-
Oct 19, 2026, 15:19Why Hematologists Should Care About Diminished Ovarian Reserve in SCD – ASH Education
-
Oct 19, 2026, 14:16Hyperfibrinolysis as an Underrecognized Cause of Bleeding
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026